(18)F-FDG PET/CT for the early prediction of the response rate and survival of patients with recurrent or metastatic breast cancer

The present study aimed to explore the value of fludeoxyglucose F 18 positron emission tomography-computed tomography (PET/CT) for the early prediction of chemotherapy remission rates and survival in patients with recurrent and metastatic breast cancer. A total of 24 patients diagnosed with recurren...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Feng-Chun, Xu, Hai-Yan, Liu, Jian-Jun, Xu, Yuan-Fan, Chen, Bin, Yang, Yi-Jin, Yan, Ning-Ning, Song, Shao-Li, Lin, Yu-Mei, Xu, Ying-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126168/
https://www.ncbi.nlm.nih.gov/pubmed/30214554
http://dx.doi.org/10.3892/ol.2018.9151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126168/
https://www.ncbi.nlm.nih.gov/pubmed/30214554
http://dx.doi.org/10.3892/ol.2018.9151

Ejemplares similares